What is rosacea? A plain-language guide

A chronic, manageable condition

Rosacea is a chronic inflammatory skin condition affecting an estimated 16 million Americans — approximately 1 in 20 US adults. The adult sex ratio is closer to 1.4 women per 1 man (Gether, 2018), not the often-repeated 3:1. It is most common in fair-skinned adults aged 30–60, and frequently appears or worsens around perimenopause.

From four subtypes to phenotypes

Since 2017, the National Rosacea Society and the global ROSCO consensus describe rosacea by phenotype — the individual features a person has — rather than by discrete subtypes, because features routinely co-occur. The four classic groupings from the older 2002 framework are still useful shorthand:

• Type 1 — persistent redness and visible vessels (formerly 'erythematotelangiectatic').
• Type 2 — inflammatory bumps and pustules, often mistaken for acne (formerly 'papulopustular').
• Type 3 — skin thickening, classically on the nose (phymatous).
• Type 4 — dry, gritty, inflamed eyes and lids (ocular).

Most people have features of more than one group at once, which is why a probabilistic quiz beats a single-label diagnosis for navigation.

Why it is misdiagnosed

Because its features mimic acne, sensitive skin, and dermatitis, many people spend months or years on the wrong routine before getting the right name for it. That delay is exactly what RosaceaClub exists to shorten.